Potential Role for the Ubiquitin Ligase SIAH2 in Modulating Bone Morphology and Adiposity
Calcified Tissue International · 2026
DOI: 10.1007/s00223-026-01596-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Calcified Tissue International, 2026. Verfasst von Matthew C Scott und 4 weiteren Autor:innen. Beteiligte Einrichtung: Pennington Biomedical Research Center, Baton Rouge, LA, 70808, USA. Hauptthemen laut MEDLINE: Adiposity, Ubiquitin-Protein Ligases, Osteogenesis, Bone and Bones. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDDK NIH HHS, American Diabetes Association, NIA NIH HHS.
Abstract (Originalsprache)
Marrow adipose expansion, with obesity or ageing, increases fracture risk. Skeletal stem cells can commit to osteoblast or adipocyte endpoints, an inverse relationship influenced by peroxisome proliferator-activated receptor gamma (PPARγ). Seven in absentia homologue 2 (SIAH2) is a ubiquitin ligase that acts in peripheral adipose tissue stromal progenitors, promoting PPARγ activity and adipogenesis. The pivotal role of PPARγ in bone marrow adipose tissue accumulation prompted us to evaluate SIAH2’s role in the balance between osteogenesis and adipogenesis. Using adherent skeletal stem and/or progenitor cells (SSPCs) isolated from the marrow of wild-type (WT) and Siah2 ^ −/− mice, we assessed in vitro osteogenic and adipogenic capacity. Bone morphology and adiposity were assessed, in vivo, using WT and Siah2 ^−/− mice in the context of dietary, high-fat diet, and pharmacological, rosiglitazone, PPARγ stimulation. We hypothesized increased osteogenesis in Siah2 ^ −/− SSPCs and expected Siah2 ^−/− mice would be resistant to the effects of PPARγ activation on trabecular morphology and marrow fat expansion. Our results show that Siah2 ^−/− SSPCs display increased capacity for both osteogenesis and adipogenesis in vitro. Further, exploratory experiments in vivo indicate Siah2 ^−/− mice have fewer, yet thicker, trabeculae on a low fat diet, while Siah2 ^−/ − mice on a high-fat diet paired with rosiglitazone trend toward more marrow adipose, decreased bone mass and increased trabecular spacing compared to WT. Our results suggest SIAH2 moderates both osteogenic and adipogenic commitment as the absence of SIAH2 results in progenitor cells that will more readily commit to either outcome. These observations underscore SIAH2’s context-specific modulatory effects on PPARγ activities determined by tissue, nutrients and pharmacological cues.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pennington Biomedical Research Center, Baton Rouge, LA, 70808, USA.
- Louisiana State University Health Sciences Center New Orleans, New Orleans, LA, 70112, USA.
- The University of Toledo, OH, 43606, Toledo, USA.
- Pennington Biomedical Research Center, Baton Rouge, LA, 70808, USA. Elizabeth.Floyd@pbrc.edu.
Förderung
- NIDDK NIH HHS
- American Diabetes Association
- NIA NIH HHS
- NCCIH NIH HHS
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Center for Complementary and Integrative Health
- National Institute on Aging
Zitieren
APA
Scott, M. C., Ghosh, B., Kilroy, G., Lecka-Czernik, B., & Floyd, Z. E. (2026). Potential Role for the Ubiquitin Ligase SIAH2 in Modulating Bone Morphology and Adiposity. Calcified Tissue International. https://doi.org/10.1007/s00223-026-01596-6
Vancouver
Scott MC, Ghosh B, Kilroy G, Lecka-Czernik B, Floyd ZE. Potential Role for the Ubiquitin Ligase SIAH2 in Modulating Bone Morphology and Adiposity. Calcified Tissue International. 2026. doi:10.1007/s00223-026-01596-6
BibTeX
@article{Scott2026,
author = {Scott, Matthew C and Ghosh, Bhaswati and Kilroy, Gail and Lecka-Czernik, Beata and Floyd, Z Elizabeth},
title = {Potential Role for the Ubiquitin Ligase SIAH2 in Modulating Bone Morphology and Adiposity},
journal = {Calcified Tissue International},
year = {2026},
doi = {10.1007/s00223-026-01596-6}
}
EUVIMED